Cellular Antiviral Factors that Target Particle Infectivity of HIV-1.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractIn the past decade, the identification and characterization of antiviral genes with the ability to interfere with virus replication has established cell-intrinsic innate immunity as a third line of antiviral defense in addition to adaptive and classical innate immunity. Understanding how cellular factors have evolved to inhibit HIV-1 reveals particularly vulnerable points of the viral replication cycle. Many, but not all, antiviral proteins share type I interferon-upregulated expression and sensitivity to viral counteraction or evasion measures. Whereas well-established restriction factors interfere with early post-entry steps and release of HIV-1, recent research has revealed a diverse set of proteins that reduce the infectious quality of released particles using individual, to date poorly understood modes of action. These include induction of paucity of mature glycoproteins in nascent virions or self-incorporation into the virus particle, resulting in poor infectiousness of the virion and impaired spread of the infection.
CitationCellular Antiviral Factors that Target Particle Infectivity of HIV-1. 2016, 14 (3):211-6 Curr. HIV Res.
AffiliationTWINCORE, Zentrum für Experimentelle und Klinische Infektionsforschung GmbH, Feodor-Lynen-Str. 7, 30625 Hannover, Germany.
JournalCurrent HIV research
The following license files are associated with this item:
- The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific.
- Authors: Lodermeyer V, Ssebyatika G, Passos V, Ponnurangam A, Malassa A, Ewald E, Stürzel CM, Kirchhoff F, Rotger M, Falk CS, Telenti A, Krey T, Goffinet C
- Issue date: 2018 Jul 15
- The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
- Authors: Trautz B, Pierini V, Wombacher R, Stolp B, Chase AJ, Pizzato M, Fackler OT
- Issue date: 2016 Dec 1
- Functional Heterogeneity of Mammalian IFITM Proteins against HIV-1.
- Authors: Marziali F, Delpeuch M, Kumar A, Appourchaux R, Dufloo J, Tartour K, Etienne L, Cimarelli A
- Issue date: 2021 Aug 25
- 90K, an interferon-stimulated gene product, reduces the infectivity of HIV-1.
- Authors: Lodermeyer V, Suhr K, Schrott N, Kolbe C, Stürzel CM, Krnavek D, Münch J, Dietz C, Waldmann T, Kirchhoff F, Goffinet C
- Issue date: 2013 Oct 24
- M2BP inhibits HIV-1 virion production in a vimentin filaments-dependent manner.
- Authors: Wang Q, Zhang X, Han Y, Wang X, Gao G
- Issue date: 2016 Sep 8